Found 49 articles for: "HS"
Hidradenitis Suppurativa Increases Risk of Postoperative Complications After Mohs Surgery: A Retrospective Cohort Study
November 2026 | Volume 25 | Issue 11 | Editorials | e98 | Copyright © November 2026
Secondary Intention Healing Over Periosteum: Challenging the Reconstruction Algorithm for Supraperiosteal Defects
September 2026 | Volume 25 | Issue 9 | Features | 877 | Copyright © September 2026
Postoperative Complication Risks in Melanoma in situ Treated With Mohs Surgery or Wide Local Excision
September 2026 | Volume 25 | Issue 9 | Editorials | e87 | Copyright © September 2026
Reining in Medicare Spending on Skin Substitutes: What the 2026 Reforms Mean for Dermatology
August 2026 | Volume 25 | Issue 8 | Features | 756 | Copyright © August 2026
Increased Postoperative Risks After Mohs Surgery in Patients With Hypothyroidism: A Cohort Study
June 2026 | Volume 25 | Issue 6 | Editorials | e58 | Copyright © June 2026
Perioperative Use of Angiotensin Inhibitors and Their Complications in Mohs Surgery: A Retrospective Cohort Study
June 2026 | Volume 25 | Issue 6 | Features | e51 | Copyright © June 2026
Minimum Margins After Positive Mohs Surgery Stages Correlate With Histologic Facing Loss
May 2026 | Volume 25 | Issue 5 | Features | 477 | Copyright © May 2026
Chronic Kidney Disease and Postoperative Complications Following Mohs Surgery: A Retrospective Cohort Study
May 2026 | Volume 25 | Issue 5 | Editorials | 486 | Copyright © May 2026
Antiviral Treatment of Herpes Simplex Virus Decreases the Risk of Alzheimer's Disease and Dementia
March 2026 | Volume 25 | Issue 3 | Original Article | 234 | Copyright © March 2026
Background: Alzheimer's disease (AD) and dementia create major global health and economic burdens. Herpes simplex virus (HSV) infects over 3 billion people, and chronic infection...
Read MoreGLP-1 Receptor Agonists in Hidradenitis Suppurativa: A Novel Therapeutic Approach for Hidradenitis Suppurativa and Its Comorbidities
December 2025 | Volume 24 | Issue 12 | Original Article | 1174 | Copyright © December 2025
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder associated with many comorbidities, including obesity, diabetes, cardiovascular risk factors, me...
Read MoreAn Open-Label, Single-Center Proof of Concept Study Evaluating the Efficacy and Safety of Tirzepatide for Moderate to Severe Hidradenitis Suppurativa
December 2025 | Volume 24 | Issue 12 | Original Article | 1246 | Copyright © December 2025
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory disease associated with obesity and metabolic dysregulation. Current therapies yield variable benefits and do ...
Read MorePerspectives and Practice Patterns of Dermatologists Using Laser Hair Removal for Hidradenitis Suppurativa
December 2025 | Volume 24 | Issue 12 | Editorials | e71 | Copyright © December 2025
Disparities in Hidradentitis Suppurativa Clinical Trials: An Updated Review of ClinicalTrials.gov from 2020 to 2024
December 2025 | Volume 24 | Issue 12 | Original Article | 1203 | Copyright © December 2025
Background: There is a notable lack of diversity in dermatologic studies, even concerning conditions that are known to have a higher prevalence in the skin of color (SOC) populat...
Read MoreMohs Micrographic Surgery in Female Genital Cancers: A Systematic Review
November 2025 | Volume 24 | Issue 11 | Original Article | 1080 | Copyright © November 2025
Background: Mohs micrographic surgery (MMS) has shown promising efficacy in female genital cancers, including Extramammary Paget’s disease (EMPD), dermatofibrosarcoma protu...
Read MoreNourishing the Skin: A Review of Diet's Role in Hidradenitis Suppurativa
November 2025 | Volume 24 | Issue 11 | Original Article | 1103 | Copyright © November 2025
Hidradenitis suppurativa (HS) is a complex skin condition influenced by both genetic and environmental factors. Increasing evidence points to diet as a key contributor to disease severity through...
Read MoreReal-World Dupilumab Persistence in United States Children, Adolescents, and Adults With Atopic Dermatitis Over 24 Months
October 2025 | Volume 24 | Issue 10 | Original Article | 996 | Copyright © October 2025
Background: Dupilumab has demonstrated benefits in patients with atopic dermatitis (AD), but there is limited information on real-world rates of dupilumab persistence and supplem...
Read MoreGlucagon-Like Peptide-1 Receptor Agonists Reduce Surgeries and Hospitalizations in Hidradenitis Suppurativa: A Multicenter TriNetX Cohort Study
September 2025 | Volume 24 | Issue 9 | Original Article | 869 | Copyright © September 2025
Background: Hidradenitis suppurativa is a chronic inflammatory skin condition frequently associated with type 2 diabetes mellitus and obesity. Glucagon-like peptide-1 receptor ag...
Read MoreEducating Through Engagement: Instagram as a Tool for Dermatology Advocacy
August 2025 | Volume 24 | Issue 8 | Editorials | e56 | Copyright © August 2025
Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey
July 2025 | Volume 24 | Issue 7 | Features | 722 | Copyright © July 2025
Recent studies have demonstrated functional and cosmetic benefits with the use of hedgehog pathway inhibitors in the neoadjuvant setting for basal cell carcinoma (BCC). This study investigated th...
Read MoreSocial Media as a Catalyst for Health Education and Early Diagnosis of Hidradenitis Suppurativa
June 2025 | Volume 24 | Issue 6 | Editorials | e45 | Copyright © June 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
